ANI Pharmaceuticals | ANIP - Ordinary Share Capital

Stock Price
70.49
Daily Change
-2.00 -2.76%
Monthly
-10.66%
Yearly
12.80%
Q1 Forecast
68.36

ANI Pharmaceuticals reported $22.49M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
ANI Pharmaceuticals USD 22.49M 760K Dec/2025
Assertio Holdings USD 9K 0 Dec/2023
Aurora Cannabis CAD 6.98B 907K Dec/2024
Canopy Growth CAD 332.38M 127.23M Sep/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Emergent BioSolutions USD 100K 0 Jun/2023
Heron Therapeutics USD 1.52M 14K Sep/2024
Hikma Pharmaceutical USD 221.89M 181.89M Dec/2025
Knight Therapeutics CAD 539.32M 1.63M Sep/2024
Nektar Therapeutics USD 19K 0 Sep/2024
Novartis USD 1.92B 17.06M Sep/2025
Omeros USD 611K 17K Dec/2023
Perrigo USD 137.6M 0 Dec/2025
Sun Pharmaceuticals INR 2.4B 35K Sep/2025
Teva Pharmaceutical Industries USD 1.15B 0 Dec/2025